From 23 to 25 October 2026, Sarajevo hosted the World Heart Failure Congress at Hotel Holiday. The event brought together local and international experts to exchange knowledge and experience in the diagnosis, treatment and ongoing care of patients with heart failure.
Dr Milan Gluhović, FESC, FHFA, from Dr Mačkić Clinic, contributed to the organisation of the congress and delivered two lectures, playing an active role in both its organisational and scientific programme.

In his lecture, “Beyond Guidelines – What Will Change Our Practice Tomorrow?”, Dr Gluhović discussed emerging scientific evidence and therapeutic approaches that could shape the future of heart failure care. Particular emphasis was placed on translating research findings into everyday clinical practice and tailoring treatment to each patient’s needs.
His second lecture, “Beyond Quadruple Therapy – Ivabradine, Vericiguat and Omecamtiv Mecarbil”, explored treatment options beyond the four foundational drug classes for heart failure with reduced ejection fraction. The presentation examined the role of ivabradine and vericiguat in selected patients, alongside research findings on omecamtiv mecarbil, clearly distinguishing established indications from approaches still under investigation.
The congress was organised through collaboration between the World Heart Failure Society and the Association of Cardiologists of Bosnia and Herzegovina, with contributions from its Working Group on Heart Failure. Hosting the event in Sarajevo provided an opportunity to strengthen professional connections and discuss ways to improve patient care.
At Dr Mačkić Clinic, participation in such events is part of our commitment to continuing medical education and professional collaboration. Bringing this knowledge and experience into daily practice helps us provide timely diagnostic assessment, individualised treatment plans and regular follow-up—essential elements of comprehensive heart failure care.
